12:00 AM
 | 
Sep 01, 2008
 |  BioCentury  |  Finance

ETF performance

ETF performance

Fund YTD return through 8/29 Net assets (A)
Remaining
Cancer (NYSE:HHK) 3% $10.3
Diagnostics (NYSE:HHD) -6%

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >